01 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
02 1BIOCON LIMITED Bangalore IN
03 1BIOCON LIMITED Bengaluru IN
04 3HETERO LABS LIMITED Hyderabad IN
05 1MATRIX PHARMACORP PRIVATE LIMITED Sangareddy IN
06 1MSN ORGANICS PRIVATE LIMITED Bibinagar Village IN
07 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
08 1ZHEJIANG HUAYI PHARMACEUTICAL CO., LTD. Yiwu CN
01 5Pioglitazone hydrochloride
02 1Pioglitazone hydrochloride, Crystalline form-I, micronised and non-micronised
03 1Pioglitazone hydrochloride, PI-process
04 1Pioglitazone hydrochloride, Process I
05 2Pioglitazone hydrochloride, Process II
01 2China
02 7India
03 1Blank
01 1Expired
02 5Valid
03 4Withdrawn by Holder
Certificate Number : CEP 2019-342 - Rev 02
Status : Valid
Issue Date : 2025-04-30
Type : Chemical
Substance Number : 2601
Pioglitazone Hydrochloride, Process I
Certificate Number : R1-CEP 2014-351 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2021-09-23
Type : Chemical
Substance Number : 2601
Certificate Number : R1-CEP 2012-340 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2018-10-31
Type : Chemical
Substance Number : 2601
Pioglitazone Hydrochloride, PI-process
Certificate Number : CEP 2023-004 - Rev 00
Status : Valid
Issue Date : 2024-08-30
Type : Chemical
Substance Number : 2601
Pioglitazone Hydrochloride, Process II
Certificate Number : R0-CEP 2017-013 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2019-04-05
Type : Chemical
Substance Number : 2601
Certificate Number : R1-CEP 2012-363 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2019-07-17
Type : Chemical
Substance Number : 2601
Pioglitazone Hydrochloride, Crystalline Form-I, ...
Certificate Number : CEP 2013-005 - Rev 01
Status : Valid
Issue Date : 2025-09-01
Type : Chemical
Substance Number : 2601
Pioglitazone Hydrochloride, Process II
Certificate Number : R1-CEP 2013-143 - Rev 01
Status : Valid
Issue Date : 2020-03-06
Type : Chemical
Substance Number : 2601
Certificate Number : R0-CEP 2013-096 - Rev 00
Status : Expired
Issue Date : 2014-11-19
Type : Chemical
Substance Number : 2601
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2012-315 - Rev 03
Status : Valid
Issue Date : 2026-05-21
Type : Chemical
Substance Number : 2601
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
71
PharmaCompass offers a list of Pioglitazone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pioglitazone Hydrochloride manufacturer or Pioglitazone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pioglitazone Hydrochloride manufacturer or Pioglitazone Hydrochloride supplier.
A C19H20N2O3S.HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of C19H20N2O3S.HCl, including repackagers and relabelers. The FDA regulates C19H20N2O3S.HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. C19H20N2O3S.HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of C19H20N2O3S.HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A C19H20N2O3S.HCl supplier is an individual or a company that provides C19H20N2O3S.HCl active pharmaceutical ingredient (API) or C19H20N2O3S.HCl finished formulations upon request. The C19H20N2O3S.HCl suppliers may include C19H20N2O3S.HCl API manufacturers, exporters, distributors and traders.
click here to find a list of C19H20N2O3S.HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A C19H20N2O3S.HCl CEP of the European Pharmacopoeia monograph is often referred to as a C19H20N2O3S.HCl Certificate of Suitability (COS). The purpose of a C19H20N2O3S.HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of C19H20N2O3S.HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of C19H20N2O3S.HCl to their clients by showing that a C19H20N2O3S.HCl CEP has been issued for it. The manufacturer submits a C19H20N2O3S.HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a C19H20N2O3S.HCl CEP holder for the record. Additionally, the data presented in the C19H20N2O3S.HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the C19H20N2O3S.HCl DMF.
A C19H20N2O3S.HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. C19H20N2O3S.HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of C19H20N2O3S.HCl suppliers with CEP (COS) on PharmaCompass.
We have 6 companies offering C19H20N2O3S.HCl
Get in contact with the supplier of your choice:
